This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
Multiple locations, including Dothan
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.From 13 Years to 17 Years
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Oklahoma City
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This study is looking at a support or therapy approach for people with Schizophrenia, schizo-affective disorder, schizofreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.
In Netherlands
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Centre Utrecht (UMCU) (Netherlands)
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Switzerland
Sponsor
Clinic of Psychiatry and Psychotherapy Bethel (Germany)
This study is testing a medication approach for people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
